Cargando…

Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL

Although the tyrosine kinase inhibitor imatinib has been shown to be an active agent in patients with gastrointestinal stromal tumours (GIST), complete remissions are almost never seen and most patients finally experience disease progression during their course of treatment. An alternative therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rikhof, B, van der Graaf, W T A, Meijer, C, Le, P T K, Meersma, G J, de Jong, S, Fletcher, J A, Suurmeijer, A J H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2008
Materias:	Translational Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584951/ https://www.ncbi.nlm.nih.gov/pubmed/18941456 http://dx.doi.org/10.1038/sj.bjc.6604736

Ejemplares similares

Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin
por: García-Santos, G, et al.
Publicado: (2012)

Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression
por: Yamana, K, et al.
Publicado: (2005)

Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation
por: Minas, V, et al.
Publicado: (2007)

Tumour-induced apoptosis in human mesothelial cells: a mechanism of peritoneal invasion by Fas Ligand/Fas interaction
por: Heath, R M, et al.
Publicado: (2004)

Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling
por: Han, Sheng, et al.
Publicado: (2017)

microRNA expression signatures of gastrointestinal stromal tumours: associations with imatinib resistance and patient outcome
por: Akçakaya, P, et al.
Publicado: (2014)

SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour
por: Pulkka, Olli-Pekka, et al.
Publicado: (2017)

Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis
por: Duiker, E W, et al.
Publicado: (2011)

Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas
por: Kelly, J D, et al.
Publicado: (2004)

Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-β expression
por: Houston, A, et al.
Publicado: (2003)

Anisomycin activates JNK and sensitises DU 145 prostate carcinoma cells to Fas mediated apoptosis
por: Curtin, J F, et al.
Publicado: (2002)

Impaired Fas-Fas Ligand Interactions Result in Greater Recurrent Herpetic Stromal Keratitis in Mice
por: Yin, Xiao-Tang, et al.
Publicado: (2015)

Stromal interaction essential for vascular endothelial growth factor A-induced tumour growth via transforming growth factor-β signalling
por: Weidenaar, A C, et al.
Publicado: (2011)

Targeting ErbB3-mediated stromal–epithelial interactions in pancreatic ductal adenocarcinoma
por: Liles, J S, et al.
Publicado: (2011)

Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine
por: Dudley, A C, et al.
Publicado: (2008)

Granulocytes mediates the Fas-L-associated apoptosis during lung metastasis of melanoma that determines the metastatic behaviour
por: Chen, Y-L, et al.
Publicado: (2002)

The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
por: Henkler, Frank, et al.
Publicado: (2005)

Use of interfering RNA to investigate the role of endogenous gastrin in the survival of gastrointestinal cancer cells
por: Grabowska, A M, et al.
Publicado: (2007)

Low stromal Foxp3(+) regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
por: McCoy, M J, et al.
Publicado: (2015)

Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients
por: Mracek, T, et al.
Publicado: (2011)

Inhibition of tyrosine kinase receptors by SU6668 promotes abnormal stromal development at the periphery of carcinomas
por: Farace, P, et al.
Publicado: (2009)

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
Publicado: (1996)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2020)

Understanding the role of Fas-Fas ligand system in bone
por: Marusic, Ana, et al.
Publicado: (2012)

Differential expressions of Fas and Fas ligand in human placenta.
por: Roh, Cheong-Rae, et al.
Publicado: (2002)

Soluble Fas and the −670 Polymorphism of Fas in Lupus Nephritis
por: Bollain-y-Goytia, Juan José, et al.
Publicado: (2014)

The Fas/FasL System in Reproduction: Survival and Apoptosis
por: Mor, Gil, et al.
Publicado: (2002)

Differential Induction of Apoptosis by Fas–Fas Ligand Interactions in Human Monocytes and Macrophages
por: Kiener, Peter A., et al.
Publicado: (1997)

Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma
por: Boroumand-Noughabi, Samaneh, et al.
Publicado: (2010)

Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma
por: Oguejiofor, K, et al.
Publicado: (2015)

Impairment of Fas-ligand–caveolin-1 interaction inhibits Fas-ligand translocation to rafts and Fas-ligand-induced cell death
por: Glukhova, Xenia A., et al.
Publicado: (2018)

The role of tumour-derived iNOS in tumour progression and angiogenesis
por: Kostourou, V, et al.
Publicado: (2011)

Intervention and the Child With FAS
por: Weiner, Lyn, et al.
Publicado: (1994)

Fas and Fas Ligand Interactions Suppress Melanoma Lung Metastasis
por: Owen-Schaub, Laurie B., et al.
Publicado: (1998)

Apoptosis role of FAS/FAS ligand system in the regulation of myelopoiesis.
por: Alenzi, Faris Q., et al.
Publicado: (2005)

Role of the Fas/FasL pathway in HIV or SIV disease
por: Poonia, Bhawna, et al.
Publicado: (2009)

Prognostic value of the Fas/Fas ligand system in breast cancer
por: Bębenek, Marek, et al.
Publicado: (2013)

Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis
por: Volpe, Elisabetta, et al.
Publicado: (2016)

Disruption of Fas-Fas Ligand Signaling, Apoptosis, and Innate Immunity by Bacterial Pathogens
por: Caulfield, Adam J., et al.
Publicado: (2014)

Dexamethasone effect on sFas/sFas ligand following cardiopulmonary bypass
por: Joashi, U, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_is3a7dvfuvuhb6fgh19a9li90k